Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDStatera Biopharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
Statera Biopharma, Inc. Earnings Date And Information
Statera Biopharma, Inc. last posted its earnings results on Thursday, May 8th, 2014. The company reported $-0.6 earnings per share for the quarter, topping analysts' consensus estimates of $-1 by $0.4. The company had revenue of 670,473 for the quarter and had revenue of 0 for the year. Statera Biopharma, Inc. has generated $-5 earnings per share over the last year ($-4.97 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Statera Biopharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, February 11th, 2024 based on prior year's report dates.
Statera Biopharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2022 | Q3 2022 | -$0.10 | $670,473 | $670,473 | ||
| 10/28/2022 | Q2 2022 | -$0.08 | $768,827 | |||
| 10/21/2022 | Q1 2022 | -$0.23 | $997,839 | |||
| 10/05/2022 | Q4 2021 | -$2.20 | $1.25 M | |||
| 11/15/2021 | Q3 2021 | -$0.47 | $236,519 | |||
| 08/16/2021 | Q2 2021 | -$0.26 | $0 | |||
| 05/14/2021 | Q1 2021 | -$0.21 | $0 | |||
| 03/22/2021 | Q4 2020 | -$0.16 | $-63,255 | |||
| 11/16/2020 | Q3 2020 | -$0.22 | $0 | |||
| 08/14/2020 | Q2 2020 | -$0.01 | $63,255 | |||
| 05/15/2020 | Q1 2020 | -$0.03 | $0 | |||
| 11/14/2019 | Q3 2019 | -$0.04 | $0 | |||
| 08/14/2019 | Q2 2019 | -$0.05 | $0 | |||
| 05/15/2019 | Q1 2019 | -$0.08 | $0 | |||
| 11/14/2018 | Q3 2018 | -$0.10 | $0 | |||
| 08/14/2018 | Q2 2018 | -$0.08 | $0 | |||
| 05/15/2018 | Q1 2018 | -$0.11 | $0 | |||
| 11/14/2017 | Q3 2017 | -$0.11 | $0 | |||
| 08/14/2017 | Q2 2017 | -$0.50 | $0 | |||
| 05/15/2017 | Q1 2017 | -$0.15 | $0 |
Statera Biopharma, Inc. Earnings: FAQ's
When is Statera Biopharma, Inc.'s earnings date?
Statera Biopharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, February 11th, 2024 based off last year's report dates.
Did Statera Biopharma, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Statera Biopharma, Inc. (:STAB) reported $-0.6 earnings per share (EPS) to beat the analysts' consensus estimate of $-1 by $0.4.
How can I listen to Statera Biopharma, Inc.'s earnings conference
call?
The conference call for Statera Biopharma, Inc.'s latest earnings report can be listened to online.
How can I read Statera Biopharma, Inc.'s conference call transcript?
The conference call transcript for Statera Biopharma, Inc.'s latest earnings report can be read online.
How much profit does Statera Biopharma, Inc. generate each year?
Statera Biopharma, Inc. (:STAB) has a recorded net income of $0. Statera Biopharma, Inc. has generated $-4.97 earnings per share over the last four quarters.
What is Statera Biopharma, Inc.'s price-to-earnings ratio?
Statera Biopharma, Inc. (:STAB) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.